Compagnie Lombard Odier SCmA’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,000
| Closed | -$2K | – | 904 |
|
|
2016
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 793 |
|
|
2016
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 881 |
|
|
2016
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 864 |
|
|
2016
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 913 |
|
|
2015
Q4 | $17K | Hold |
1,000
| – | – | ﹤0.01% | 808 |
|
|
2015
Q3 | $21K | Hold |
1,000
| – | – | ﹤0.01% | 696 |
|
|
2015
Q2 | $50K | Hold |
1,000
| – | – | ﹤0.01% | 645 |
|
|
2015
Q1 | $78K | Buy |
+1,000
| New | +$78K | ﹤0.01% | 709 |
|